avian
infecti
bronchiti
viru
first
cov
isol
differ
cov
subsequ
isol
infect
rodent
domest
anim
includ
mous
pig
cow
turkey
cat
dog
cov
believ
caus
human
diseas
chang
success
isol
hcov
strain
clinic
specimen
patient
common
cold
serial
passag
inoculum
tracheal
organ
cultur
sever
novel
hcov
describ
character
perform
case
known
caus
agent
common
cold
upper
respiratori
tract
infect
account
case
common
cold
prototyp
strain
isol
use
tracheal
organ
cultur
isol
organ
cultur
subsequ
serial
passag
brain
suckl
mice
clinic
featur
infect
character
human
volunt
studi
case
natur
infect
hcov
result
mild
common
coldlik
symptom
sever
lower
respiratori
tract
infect
develop
immunocompromis
patient
apart
respiratori
infect
suspect
infect
central
nervou
system
cn
mrna
covlik
particl
detect
cn
sampl
patient
multipl
sclerosi
claim
support
suscept
human
neural
primari
cultur
howev
influenc
develop
progress
multipl
sclerosi
await
investig
presar
era
gener
accept
hcov
caus
mild
respiratori
diseas
concept
chang
emerg
sarscov
first
report
case
sarscov
infect
retrospect
date
back
novemb
guangdong
provinc
china
subsequ
seven
month
sar
epidem
result
report
case
countri
case
fatal
superspread
event
sarscov
transmiss
caus
fear
societi
although
exact
caus
superspread
remain
understood
host
viru
thought
play
key
role
releas
larg
amount
virion
superspread
regard
use
immunosuppress
agent
highdos
steroid
earli
phase
viral
infect
treatment
modal
might
boost
viral
replic
lead
shed
larg
amount
viru
likewis
immunocompromis
statu
superspread
could
effect
addit
mutat
viru
suscept
gene
encod
restrict
factor
implic
host
antivir
defenc
would
also
result
shed
extraordinarili
larg
quantiti
viru
word
compromis
host
antivir
defenc
decoupl
host
antivir
immun
respons
viral
replic
might
allow
facilit
superspread
sarscov
isol
identifi
caus
agent
sar
unlik
sarscov
infect
caus
lower
respiratori
tract
infect
accompani
cytokin
storm
patient
poor
outcom
lifethreaten
ard
develop
critic
ill
patient
apart
respiratori
infect
gastrointestin
cn
infect
also
found
patient
sar
cell
play
import
role
discoveri
sarscov
chicken
embryo
cov
includ
avian
infecti
bronchiti
viru
isol
cultur
cell
highli
suscept
sarscov
infect
type
interferondefect
consist
infect
mice
sarscov
result
lethal
outcom
profibrot
phenotyp
lung
mice
clear
viru
highlight
import
host
antivir
respons
control
sarscov
infect
cellular
organism
level
postsar
era
cov
research
brought
back
limelight
effort
put
search
novel
hcov
search
fruit
two
new
hcov
identifi
human
sampl
posit
hcov
sarscov
first
isol
child
suffer
bronchiol
patient
pneumonia
respect
difficult
cultur
propag
primari
human
airway
epitheli
cell
cultur
interfac
similar
found
worldwid
caus
mild
respiratori
diseas
particularli
infect
associ
virusinduc
croup
children
four
virus
communityacquir
hcov
well
adapt
human
rare
case
might
accident
mutat
caus
sever
lower
respiratori
tract
diseas
exampl
subtyp
recent
found
associ
sever
lower
respiratori
tract
infect
china
anoth
highli
pathogen
hcov
outbreak
emerg
saudi
arabia
new
hcov
subsequ
name
merscov
isol
patient
develop
acut
pneumonia
renal
failur
export
mer
case
also
report
outsid
arabian
peninsula
occasion
one
rel
big
secondari
outbreak
confirm
case
occur
south
korea
januari
laboratoryconfirm
case
report
case
fatal
clinic
symptom
divers
mer
patient
rang
asymptomat
ard
acut
renal
injuri
uniqu
mer
patient
commonli
observ
middl
east
south
korea
merscov
replic
well
mani
differ
type
cell
extrapulmonari
tissu
includ
kidney
intestin
tract
merscov
endem
arabian
peninsula
sporad
recurr
outbreak
occur
continu
sinc
anim
origin
hcov
support
similar
genom
organ
phylogenet
related
anim
cov
hcov
well
geograph
coincid
virus
plausibl
rout
crossspeci
transmiss
pet
butcher
close
contact
errorpron
rnadepend
rna
polymeras
creat
divers
cov
genom
enabl
jump
across
speci
barrier
howev
hcov
encod
proofread
exoribonucleas
exon
play
crucial
role
rna
synthesi
replic
fidel
serv
reduc
error
rna
replic
inactiv
exon
caus
mutat
phenotyp
result
viru
either
attenu
inviabl
addit
structur
nonstructur
gene
might
also
contribut
genom
divers
cov
modul
polymeras
exon
activ
addit
mutat
recombin
delet
also
play
import
role
host
switch
adapt
among
sarscov
merscov
mutat
rate
high
nucleotid
substat
per
base
per
year
document
sarscov
compar
primat
lentivirus
includ
hiv
compar
sarscov
variabl
merscov
genom
much
less
dramat
interest
clarifi
might
relat
host
adapt
regard
adapt
mutat
protein
sarscov
found
outbreak
result
better
bind
receptor
cryoem
analysi
provid
structur
evid
protein
bind
higher
affin
interest
see
whether
might
adapt
near
futur
sinc
receptorbind
domain
also
contain
predomin
neutral
epitop
variat
domain
relev
develop
vaccin
hcov
zoonot
origin
wherea
bat
evolutionari
reservoir
host
sarscov
merscov
parent
virus
found
rodent
intermedi
amplifi
host
hcov
also
found
domest
wild
mammal
ancestor
identifi
domest
anim
cattl
swine
switch
host
cattl
pig
human
might
occur
context
pandem
respiratori
diseas
record
around
human
histori
similar
merscov
could
acquir
human
dromedari
camel
howev
direct
crossspeci
transmiss
remain
determin
possibl
exclud
human
camel
might
acquir
unidentifi
host
includ
bat
effort
identifi
direct
anim
sourc
sarscov
sarscovrel
cov
sarsrcov
share
sequenc
homolog
nucleotid
level
sarscov
isol
worker
work
live
anim
market
anim
meat
sold
anim
market
includ
himalayan
palm
civet
raccoon
dog
palm
civet
thought
natur
host
sarscov
antisarscov
antibodi
detect
civet
market
experiment
infect
civet
equal
suscept
sarscov
sarsrcov
infect
anim
display
clinic
symptom
howev
antisarscov
antibodi
detect
wild
farm
civet
rais
possibl
natur
host
sarscov
sarsrcov
horsesho
bat
identifi
natur
host
sarsrcov
bat
sarsrcov
serv
gene
pool
evolutionari
origin
sarscov
particularli
noteworthi
sarsrcov
use
receptor
sarscov
also
found
bat
genom
share
nucleotid
sequenc
homolog
presum
palm
civet
mammal
market
transient
infect
transmit
viru
human
remain
clarifi
whether
anoth
stabl
natur
reservoir
host
sarscov
exactli
like
dromedari
camel
merscov
might
exist
genom
sequenc
merscov
close
relat
bat
cov
bat
cov
evolutionarili
closer
merscov
share
nucleotid
sequenc
homolog
use
receptor
also
identifi
although
bat
evolutionari
reservoir
host
bat
cov
serv
gene
pool
merscov
human
acquir
merscov
diseas
dromedari
camel
directli
bat
camel
natur
reservoir
host
merscov
merscov
isol
dromedari
ident
found
human
experiment
infect
dromedari
camel
merscov
result
mild
diseas
shed
larg
quantiti
viru
upper
respiratori
tract
addit
noncamelid
domest
anim
close
contact
infect
camel
includ
sheep
goat
cow
donkey
also
infect
merscov
domest
anim
could
also
pose
risk
human
therefor
includ
merscov
surveil
programm
found
share
nucleotid
homolog
bat
cov
found
rhinolophu
affini
bat
howev
receptorbind
domain
protein
differ
significantli
earliest
patient
infect
link
huanan
seafood
wholesal
market
live
anim
market
wuhan
hubei
china
detect
work
environ
market
support
exist
live
anim
sourc
bamboo
rat
famili
rhizomyida
civet
prime
suspect
intermedi
host
although
concret
evid
avail
metagenom
analysi
cov
sequenc
indic
pangolin
group
endang
small
mammal
carri
betacoronavirus
high
rate
includ
share
nucleotid
homolog
pangolin
betacoronavirus
phylogenet
relat
exist
evid
suggest
neither
pangolin
betacoronavirus
might
immedi
ancestor
investig
requir
determin
whether
pangolin
anim
might
harbour
parent
virus
serv
intermedi
amplifi
host
fli
mammal
bat
known
natur
reservoir
variou
human
pathogen
virus
includ
limit
rabi
viru
nipah
hendra
virus
ebola
viru
influenza
virus
directli
transmit
rabi
viru
nipah
hendra
virus
ebola
viru
human
ebola
viru
might
also
transmit
human
indirectli
fruit
contamin
fruit
bat
african
forest
due
larg
geograph
distribut
great
divers
bat
speci
larg
number
bat
cov
creat
intergenu
interspeci
transmiss
recombin
covinfect
bat
asymptomat
mild
symptom
suggest
cov
bat
mutual
adapt
high
degre
particularli
bat
well
adapt
cov
anatom
physiolog
first
high
level
reactiv
oxygen
speci
ro
gener
high
metabol
activ
may
suppress
cov
replic
bat
manag
level
second
degener
inflammatori
sensor
signal
pathway
bat
attenu
virusinduc
patholog
particularli
inflammasom
activ
defect
bat
third
constitut
activ
type
iii
interferon
product
innat
immun
respons
suppress
viral
replic
persist
express
interferonstimul
gene
specul
endogen
retrovirus
bat
help
sustain
interferon
stimul
bat
hand
sting
signal
defect
bat
might
lead
select
repress
subset
interferonstimul
gene
final
upregul
inhibitori
natur
killer
cell
receptor
low
express
level
major
histocompat
complex
class
molecul
bat
may
hinder
natur
killer
cell
activ
uniqu
featur
empow
bat
surviv
cov
infect
coexist
larg
number
bat
cov
moreov
high
metabol
rate
bat
may
provid
select
pressur
gener
highli
pathogen
viru
strain
high
ro
level
bat
mutagen
affect
proofread
cov
polymeras
pathogen
cov
strain
may
gener
recombin
lead
acquir
novel
protein
protein
featur
host
adapt
bat
averag
life
span
year
long
life
span
possibl
establish
persist
viru
infect
bat
increas
chanc
crossspeci
transmiss
bat
cov
hiv
studi
virus
histori
best
model
understand
interplay
viru
host
antivir
defenc
trace
origin
hiv
would
provid
framework
us
understand
crossspeci
transmiss
pathogen
comparison
hiv
would
reveal
common
theme
requir
success
speci
jump
particular
lesson
learnt
hiv
highli
relev
instruct
follow
reason
first
hiv
zoonot
origin
second
infect
reservoir
host
parent
virus
hiv
result
mild
symptom
howev
infect
human
much
sever
symptom
develop
third
similar
differ
resembl
sarscov
final
hiv
plausibl
deriv
discret
crossspeci
transmiss
event
anim
human
thu
briefli
review
current
understand
origin
hiv
host
antihiv
defenc
shape
emerg
pandem
hiv
strain
persuas
evid
hiv
deriv
multipl
crossspeci
transmiss
simian
immunodefici
virus
siv
natur
infect
african
nonhuman
primat
pandem
strain
group
origin
singl
transmiss
event
chimpanze
harbour
sivcpz
near
cameroon
central
africa
multipl
transmiss
event
siv
chimpanze
human
also
detect
result
virus
group
n
p
spread
human
limit
extent
group
found
ten
thousand
peopl
westcentr
africa
group
n
p
identifi
individu
respect
likewis
appreci
spread
within
human
seen
group
b
result
two
crossspeci
transmiss
sivsmm
sooti
mangabey
west
africa
group
found
singl
individu
thu
origin
one
two
primatetohuman
transmiss
event
transmiss
event
unproduct
repres
incid
secondari
tertiari
spread
limit
siv
nonpathogen
natur
host
transmiss
new
host
human
well
macaqu
sivmac
enabl
becom
highli
pathogen
share
nucleotid
sequenc
homolog
transmiss
rate
lower
viral
load
gener
lower
infect
individu
natur
histori
infect
quit
differ
although
clinic
symptom
acquir
immunodefici
syndrom
aid
caus
indistinguish
peopl
infect
progress
aid
one
strong
predictor
diseas
progress
distinguish
pathogen
hiv
infect
nonpathogen
siv
infect
activ
host
antivir
defenc
includ
promin
stimul
cell
former
latter
anoth
possibl
natur
host
siv
might
survivor
ancient
siv
pandem
one
predict
hiv
human
eventu
adapt
like
siv
natur
host
regard
aid
might
consid
accid
hiv
fail
adapt
human
human
fail
adapt
hiv
support
view
speciesspecif
featur
host
restrict
factor
tetherin
prevent
siv
infect
human
hand
adapt
mutat
accessori
gene
vpu
nef
vif
hiv
found
counteract
host
restrict
factor
constitut
antivir
defenc
hostspecif
manner
exampl
fivecodon
delet
cytoplasm
domain
human
restrict
factor
tetherin
result
prevent
interact
sivcpz
nef
human
side
viru
strain
use
vpu
protein
degrad
tetherin
origin
anoth
pair
human
retrovirus
name
human
lymphotrop
virus
also
similar
relev
hcov
share
nucleotid
sequenc
homolog
wherea
caus
highli
lethal
diseas
name
adult
tcell
leukaemia
anoth
immunemedi
disord
spinal
cord
relat
viru
larg
nonpathogen
nononcogen
virus
counterpart
nonhuman
primat
newli
discov
cameroonian
hunter
nonhuman
primat
least
four
crossspeci
transmiss
event
htlv
identifi
involv
differ
speci
primat
spread
limit
human
infect
million
peopl
infect
lymphocyt
provid
good
exampl
asymptomat
infect
human
hiv
sarscov
bear
mani
similar
term
crossspeci
transmiss
difficult
predict
ongo
outbreak
might
develop
come
week
month
unpreced
measur
taken
isol
sourc
infect
block
humantohuman
transmiss
protect
suscept
individu
remain
seen
whether
extent
secondari
tertiari
spread
weaken
prevent
control
measur
appar
intrafamili
transmiss
stop
epicentr
wuhan
januari
citi
lock
human
gather
prohibit
also
remain
determin
percentag
gener
popul
wuhan
infect
import
research
question
set
prioriti
howev
seen
everi
animaltohuman
transmiss
event
give
rise
viru
highli
sustain
transmiss
within
human
transmiss
might
stop
due
intrins
characterist
viru
action
human
restrict
factor
human
intervent
measur
anoth
possibl
becom
highli
transmiss
within
human
like
four
communityacquir
hcov
estim
transmiss
rate
express
reproduct
number
fall
within
rang
higher
sarscov
tabl
sustain
well
adapt
human
ultim
fortun
also
becom
less
pathogen
resembl
plausibl
initi
cross
speci
barrier
infect
human
decad
centuri
ago
might
also
caus
pandem
human
suffer
sever
respiratori
diseas
mention
one
pandem
record
end
nineteenth
centuri
link
jump
cattl
human
virus
lineag
sarscov
similar
tabl
share
nucleotid
sequenc
homolog
known
interferon
antagonist
encod
sarscov
includ
n
protein
respect
share
amino
acid
sequenc
ident
counterpart
known
activ
inflammasom
encod
sarscov
includ
e
respect
share
amino
acid
ident
counterpart
noteworthi
accessori
protein
modul
interferon
respons
inflammasom
activ
two
virus
vari
substanti
interest
see
whether
diverg
might
affect
virul
pathogen
comparison
sequenc
genom
organ
sarscov
reveal
similar
differ
overemphas
differ
initi
stage
outbreak
turn
counterproduct
costli
diseas
control
sequenc
similar
predict
pattern
mode
interact
host
antivir
defenc
would
similar
inde
share
mani
featur
cours
infect
first
share
cellular
receptor
second
transmiss
rout
pattern
similar
transmit
droplet
primarili
close
contact
major
risk
factor
attack
rate
within
famili
context
even
higher
sarscov
rout
transmiss
report
case
sarscov
studi
requir
elucid
exact
role
transmiss
spread
third
superspread
event
document
sarscov
also
suspect
occur
transmiss
could
explain
rapid
increas
confirm
case
mani
place
includ
diamond
princess
cruis
ship
februari
fourth
clinic
present
sarscov
infect
similar
although
symptom
associ
infect
gener
milder
fifth
host
antivir
defenc
play
critic
role
cours
sarscov
infect
sever
case
immunopathogenesi
induct
proinflammatori
cytokin
storm
culprit
final
drug
test
effect
sarscov
shown
exhibit
effect
exampl
includ
nucleotid
analogu
remdesivir
proteas
inhibitor
lopinavir
ritonavir
well
interferon
particularli
activ
innat
antivir
respons
interferon
benefici
effect
least
initi
stage
infect
howev
caution
still
observ
possibl
interferon
might
exacerb
inflamm
late
phase
infect
exclud
innat
immun
stimul
also
test
effect
futur
vitro
vivo
experi
asymptomat
carrier
report
first
studi
famili
cluster
transmiss
asymptomat
carrier
close
contact
later
suggest
subsequ
challeng
howev
even
famili
member
close
contact
could
infect
index
patient
presymptomat
window
period
claim
still
worthi
signific
concern
presum
transmiss
asymptomat
carrier
famili
member
recent
document
exist
mani
asymptomat
carrier
presymptomat
patient
patient
mild
symptom
post
huge
challeng
infect
control
transmiss
peopl
suscept
group
would
difficult
prevent
number
peopl
infect
could
underestim
howev
exist
evid
suggest
risk
might
probabl
lower
expect
first
asymptomat
carrier
common
first
famili
cluster
care
studi
one
six
famili
member
found
asymptomat
present
nonspecif
mild
symptom
typic
groundglass
opac
one
lung
second
transmiss
asymptomat
carrier
presymptomat
patient
could
even
less
common
viral
load
low
viru
shed
substanti
key
question
concern
often
asymptomat
presymptomat
viru
shed
might
occur
well
whether
viral
load
could
high
asymptomat
carrier
hcov
includ
well
document
importantli
detect
rate
viru
group
lower
viral
load
much
lower
compar
patient
upper
respiratori
tract
symptom
gener
consist
notion
asymptomat
presymptomat
shed
might
less
common
estim
half
half
regard
epidemiolog
studi
determin
percentag
asymptomat
carrier
select
larg
cohort
subject
wuhan
help
clarifi
role
asymptomat
viru
shed
transmiss
analysi
also
rule
rule
predict
asymptomat
viru
shed
exist
uncommon
sinc
patient
nonspecif
mild
symptom
well
asymptomat
carrier
go
undetect
easili
chanc
establish
human
increas
like
becom
either
endem
region
pandem
theoret
asymptomat
carrier
might
aris
host
antivir
defenc
either
strong
decoupl
immun
respons
effect
limit
could
complet
block
replic
asymptomat
shed
might
occur
scenario
risk
transmit
other
rel
low
low
viral
load
altern
immun
respons
decoupl
viral
replic
infect
natur
primat
host
siv
viral
load
would
higher
pose
higher
risk
persontoperson
transmiss
care
quantit
analysi
replic
dynam
asymptomat
carrier
time
requir
clarifi
valid
two
model
cov
believ
exist
year
molecular
clock
analysi
enabl
us
deduc
time
emerg
crossspeci
transmiss
hcov
surprisingli
highli
pathogen
sarscov
merscov
thought
emerg
last
year
although
low
pathogen
isol
postsar
era
time
emerg
earlier
two
highli
pathogen
virus
wherea
emerg
year
ago
origin
date
back
word
sarscov
merscov
repres
newcom
strive
adapt
human
wherea
communityacquir
hcov
includ
better
adapt
result
molecular
date
hcov
suggest
attenu
might
favour
evolut
host
adapt
take
place
shed
light
trend
compar
analysi
innat
immunomodulatori
activ
viral
protein
encod
differ
hcov
would
help
first
place
type
interferon
antagon
protein
might
compar
use
interferon
treat
hcovinfect
patient
test
earli
variou
volunt
experi
perform
investig
human
combat
hcov
infect
administr
interferon
amelior
sever
symptom
volunt
suggest
interferon
confer
protect
infect
inde
potent
induc
type
interferon
replic
suscept
inhibit
type
ifn
suggest
interferon
serv
key
compon
host
antivir
defenc
sinc
interferon
effect
suppress
earli
phase
viral
replic
suppress
interferon
product
signal
highli
pathogen
hcov
exacerb
diseas
progress
thu
highli
pathogen
hcov
adopt
variou
countermeasur
suppress
host
interferon
product
signal
review
elsewher
host
innat
immun
respons
firstlin
defenc
trigger
type
interferon
type
interferon
product
activ
detect
replic
viral
rna
cytoplasm
rna
sensor
rigi
oligomer
adaptor
protein
mav
induc
activ
rna
sensor
lead
format
complex
phosphoryl
transcript
factor
drive
type
ifn
transcript
highli
pathogen
hcov
often
encod
viral
protein
higher
capabl
antagon
rnainduc
type
interferon
product
perturb
rna
sens
one
exampl
doublestrand
rna
dsrna
bind
domain
merscov
respons
suppress
sendai
viru
poli
c
induc
type
interferon
product
gain
dsrnabind
abil
observ
bat
cov
suggest
function
gain
merscov
might
acquir
later
stage
evolut
anoth
exampl
protein
highli
pathogen
cov
sarscov
merscov
report
potent
suppress
type
interferon
product
suggest
loss
activ
might
taken
place
viral
evolut
lead
attenu
suppress
type
interferon
induct
alphacoronavirus
betacoronavirus
use
degrad
host
mrna
transcript
result
suppress
host
interferon
respons
although
sequenc
homolog
protein
two
genera
remain
low
conserv
domain
present
alphacoronavirus
respons
shutdown
host
gene
express
delet
amino
acid
partial
restor
host
gene
express
shown
luciferas
report
assay
interferonmodul
activ
show
variat
within
genu
betacoronaviru
wherea
protein
encod
sarscov
bat
cov
potent
suppress
induct
type
interferon
counterpart
bat
cov
bat
cov
rel
weak
interferon
suppressor
degre
conserv
interferon
antagon
seen
among
differ
cov
apart
prevent
interferon
product
cov
protein
also
evolv
suppress
interferon
effector
signal
one
bestcharacter
exampl
oligoadenyl
synthetas
oa
rnase
l
pathway
upon
activ
interferon
respons
sens
dsrna
transcript
express
oa
induc
catalys
synthesi
serv
second
messeng
activ
rnase
l
limit
viral
replic
cleavag
cellular
viral
singlestrand
rna
cleav
rna
fragment
turn
prime
rna
sensor
amplifi
interferon
product
infect
cell
counter
rnase
l
activ
cov
evolv
phosphodiesteras
cleav
first
cov
phosphodiesteras
identifi
mous
hepat
viru
protein
sequenc
align
multipl
cov
includ
bat
cov
well
encod
merscov
similar
mous
hepat
viru
viral
protein
preserv
phosphodiesteras
activ
suggest
cov
develop
import
enzymat
activ
converg
diverg
henc
although
hcov
retain
one
anoth
strategi
counter
host
antivir
defenc
highli
pathogen
cov
particularli
power
suppress
host
immun
capabl
might
weaken
lost
adapt
human
although
exact
mechan
might
counteract
host
antivir
defenc
remain
elucid
emerg
viru
thought
less
pathogen
sarscov
predict
ifn
antagon
abil
suppress
pathway
innat
antivir
signal
might
fall
sarscov
communityacquir
hcov
plausibl
weaken
ifn
antagon
compar
sarscov
might
lead
robust
host
antivir
defenc
attenu
viral
replic
lower
pathogen
apart
potent
suppress
interferonmedi
antivir
respons
highli
pathogen
hcov
often
induc
massiv
cell
death
cytopathi
cell
death
doubleedg
sword
play
antivir
provir
role
viral
infect
one
hand
part
host
antivir
defenc
provid
dead
end
viral
replic
infect
often
price
patholog
chang
includ
inflamm
hand
die
dead
cell
releas
larg
number
virion
facilit
viral
dissemin
one
form
cell
death
known
pyroptosi
one
result
proinflammatori
cytokin
storm
drive
least
part
high
pathogen
sarscov
merscov
poor
outcom
patient
sar
mer
often
associ
exceedingli
high
level
proinflammatori
cytokin
lower
respiratori
tract
tissu
upregul
inflammatori
cytokin
includ
interleukin
il
observ
sarscovinfect
monocytederiv
human
dendrit
cell
tissu
model
matur
gener
proteolyt
cleavag
caspas
activ
requir
format
multiprotein
complex
term
inflammasom
danger
signal
sens
cell
activ
recruit
asc
facilit
oligomer
full
activ
inflammasom
activ
two
signal
respect
stimul
transcript
signal
cleav
signal
requir
recombin
sarscov
either
delet
defect
ion
channel
activ
e
protein
compromis
activ
matur
secret
mechanist
e
activ
signal
stimul
activ
result
activ
transcript
particular
achiev
ubiquitin
activ
second
signal
ion
channel
activ
sarscov
e
protein
promot
assembl
inflammasom
differ
mechan
suggest
sarscov
inflammasom
activ
demonstr
sarscov
promot
inflammasom
assembl
ubiquitin
asc
altern
sarscov
might
provid
potassium
flux
ion
channel
domain
activ
inflammasom
investig
requir
resolv
discrep
figur
nevertheless
enhanc
secret
mediat
sarscov
e
protein
might
contribut
induct
proinflammatori
cytokin
storm
sinc
promot
express
proinflammatori
cytokin
tumour
necrosi
factor
thu
smallmolecul
inhibitor
inflammasom
might
prove
use
treatment
merit
preclin
clinic
studi
apart
cytokin
storm
pyroptosi
observ
highli
pathogen
hcov
cell
death
programm
apoptosi
necrosi
might
also
contribut
pathogenesi
apoptosi
detect
variou
hcovinfect
sampl
deriv
respiratori
tract
also
extrapulmonari
site
autopsi
studi
sar
casualti
reveal
massiv
apoptosi
multipl
organ
includ
liver
thyroid
gland
merscov
induc
apoptosi
kidney
lung
primari
lymphocyt
plausibl
induct
delin
cov
might
activ
apoptosi
pathway
analysi
perform
cov
protein
e
protein
sarscov
proapoptot
sarscov
protein
activ
intrins
pathway
apoptosi
interact
antiapoptot
protein
bclxl
endoplasm
reticulum
therebi
sequest
key
suppressor
apoptosi
merscov
infect
activ
intrins
extrins
pathway
apoptosi
exacerb
viral
pathogenesi
apoptosi
sarscov
induc
necrosi
induct
oligomer
gener
highli
pathogen
hcov
capabl
activ
differ
cell
death
programm
effici
regard
great
interest
see
whether
lower
pathogen
higher
humantohuman
transmiss
might
link
abil
modul
inflammasom
activ
cell
death
programm
select
outbreak
provid
unpreced
opportun
us
keep
track
zoonot
cov
cross
speci
barrier
infect
human
whether
transmiss
within
human
come
dead
end
depend
primarili
whether
viru
acquir
abil
transmit
persontoperson
effici
sustain
case
merscov
sarscov
secondari
tertiari
spread
becom
weaken
give
opportun
quarantin
measur
human
intervent
take
effect
humantohuman
transmiss
sustain
howev
transmiss
compar
four
communityacquir
hcov
influenza
virus
prepar
well
arriv
anoth
communityacquir
hcov
regard
crucial
determin
infect
rate
epicentr
wuhan
serolog
real
ratio
asymptomat
carrier
patient
mild
symptom
well
transmiss
rate
secondari
tertiari
quaternari
spread
also
pivot
attack
rate
suffici
high
tremend
challeng
contain
spread
herd
immun
develop
virul
pathogen
seem
lie
sarscov
communityacquir
hcov
becom
attenu
adapt
well
human
increas
persontoperson
transmiss
anticip
similar
strategi
prevent
control
cov
influenza
virus
might
adopt
reduc
morbid
mortal
caus
vaccin
could
develop
quarantin
contain
spread
necessari
vaccin
provid
second
opportun
erad
human
interplay
host
antivir
defenc
core
viral
pathogenesi
also
determin
infect
outcom
might
explain
exist
risk
asymptomat
carrier
similar
sarscov
mani
aspect
lesson
human
pathogen
virus
includ
sarscov
communityacquir
hcov
influenza
virus
hiv
enlighten
help
howev
also
novel
human
pathogen
may
interact
host
antivir
defenc
uniqu
manner
basic
research
field
interact
hold
key
mani
import
question
diseas
control
prevent
mani
import
question
concern
ident
mechan
interferon
antagonist
encod
answer
month
year
come
particularli
compar
analys
sarscov
advanc
understand
pathogenesi
new
knowledg
gain
guid
develop
vaccin
therapeut
